Aurinia Completes Final Patient Treatment in AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for Dry Eye Syndrome Biotech Investing
European Commission Grants Marketing Authorization for Jyseleca® ? for the Treatment of Adults With Moderate to Severe Active Rheumatoid Arthritis Biotech Investing
FDA Approves Bausch + Lomb Alaway® Preservative Free Ophthalmic Solution, 0.035% Medical Device Investing
Cardiol Therapeutics Receives FDA Approval for Investigational New Drug Application for Phase II/III COVID-19 Trial Biotech Investing
Opdivo Significantly Improves Disease Free-Survival vs. Placebo as Adjuvant Therapy for Patients with High-Risk, Muscle-Invasive Urothelial Carcinoma in Phase 3 CheckMate -274 Trial Biotech Investing
